39 related articles for article (PubMed ID: 14633680)
1. Enhancement of Bik antitumor effect by Bik mutants.
Li YM; Wen Y; Zhou BP; Kuo HP; Ding Q; Hung MC
Cancer Res; 2003 Nov; 63(22):7630-3. PubMed ID: 14633680
[TBL] [Abstract][Full Text] [Related]
2. A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis.
Wang Y; Guan X; Fok KL; Li S; Zhang X; Miao S; Zong S; Koide SS; Chan HC; Wang L
Cell Mol Life Sci; 2008 Nov; 65(23):3822-9. PubMed ID: 18953687
[TBL] [Abstract][Full Text] [Related]
3. Bik promotes proteasomal degradation to control low-grade inflammation.
Mebratu YA; Jones JT; Liu C; Negasi ZH; Rahman M; Rojas-Quintero J; O'Connor GT; Gao W; Dupuis J; Cho MH; Litonjua AA; Randell S; Tesfaigzi Y
J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38113109
[TBL] [Abstract][Full Text] [Related]
4. Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes.
Cui Y; Yuan Q; Chen J; Jiang J; Guan H; Zhu R; Li N; Liu W; Wang C
Front Endocrinol (Lausanne); 2023; 14():1127441. PubMed ID: 37223030
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase II activates Bik to induce death of hyperplastic mucous cells in a cell cycle-dependent manner.
Mebratu YA; Imani J; Jones JT; Tesfaigzi Y
J Cell Physiol; 2022 Feb; 237(2):1561-1572. PubMed ID: 34741311
[TBL] [Abstract][Full Text] [Related]
6. Viroimmunotherapy for breast cancer: promises, problems and future directions.
Chaurasiya S; Fong Y
Cancer Gene Ther; 2021 Aug; 28(7-8):757-768. PubMed ID: 33268826
[TBL] [Abstract][Full Text] [Related]
7. BIK ubiquitination by the E3 ligase Cul5-ASB11 determines cell fate during cellular stress.
Chen FY; Huang MY; Lin YM; Ho CH; Lin SY; Chen HY; Hung MC; Chen RH
J Cell Biol; 2019 Sep; 218(9):3002-3018. PubMed ID: 31387940
[TBL] [Abstract][Full Text] [Related]
8. Does the BCL-2 family member BIK control lung carcinogenesis?
Mebratu YA; Tesfaigzi Y
Mol Cell Oncol; 2018; 5(4):e1435182. PubMed ID: 30250907
[TBL] [Abstract][Full Text] [Related]
9. The impact of phosphatases on proliferative and survival signaling in cancer.
Narla G; Sangodkar J; Ryder CB
Cell Mol Life Sci; 2018 Aug; 75(15):2695-2718. PubMed ID: 29725697
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
[TBL] [Abstract][Full Text] [Related]
11. Cell Death Signaling.
Green DR; Llambi F
Cold Spring Harb Perspect Biol; 2015 Dec; 7(12):. PubMed ID: 26626938
[TBL] [Abstract][Full Text] [Related]
12. Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma.
Dai HY; Chen HY; Lai WC; Hung MC; Li LY
Oncotarget; 2015 Sep; 6(27):23807-19. PubMed ID: 26247632
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition enhances the killing effect of BikDD gene therapy.
Sun Y; Ponz-Sarvise M; Chang SS; Chang WC; Chen CH; Hsu JL; Hung MC
Am J Transl Res; 2015; 7(2):319-27. PubMed ID: 25901200
[TBL] [Abstract][Full Text] [Related]
14. Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.
Xie X; Kong Y; Tang H; Yang L; Hsu JL; Hung MC
Mol Cancer Ther; 2014 Jul; 13(7):1813-25. PubMed ID: 24785255
[TBL] [Abstract][Full Text] [Related]
15. BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer.
Jiao S; Wu M; Ye F; Tang H; Xie X; Xie X
PLoS One; 2014; 9(3):e92172. PubMed ID: 24637719
[TBL] [Abstract][Full Text] [Related]
16. The importance of serine 776 in Ataxin-1 partner selection: a FRET analysis.
Menon RP; Soong D; de Chiara C; Holt MR; Anilkumar N; Pastore A
Sci Rep; 2012; 2():919. PubMed ID: 23213356
[TBL] [Abstract][Full Text] [Related]
17. Human embryonic stem cells express elevated levels of multiple pro-apoptotic BCL-2 family members.
Madden DT; Davila-Kruger D; Melov S; Bredesen DE
PLoS One; 2011; 6(12):e28530. PubMed ID: 22174832
[TBL] [Abstract][Full Text] [Related]
18. BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment.
Lang JY; Hsu JL; Meric-Bernstam F; Chang CJ; Wang Q; Bao Y; Yamaguchi H; Xie X; Woodward WA; Yu D; Hortobagyi GN; Hung MC
Cancer Cell; 2011 Sep; 20(3):341-56. PubMed ID: 21907925
[TBL] [Abstract][Full Text] [Related]
19. BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.
Bodet L; Ménoret E; Descamps G; Pellat-Deceunynck C; Bataille R; Le Gouill S; Moreau P; Amiot M; Gomez-Bougie P
Br J Cancer; 2010 Dec; 103(12):1808-14. PubMed ID: 21063407
[TBL] [Abstract][Full Text] [Related]
20. Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer.
Lan KL; Ou-Yang F; Yen SH; Shih HL; Lan KH
Clin Exp Metastasis; 2010 May; 27(5):307-18. PubMed ID: 20373131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
